SynthesisPloS one2017

Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.

Astrid Yeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.